bmiMD Review: A Broad, Cheap Menu — Let Down by Fees You Weren't Told About

What Is bmiMD?

bmiMD is a telehealth weight-loss and wellness provider operating from 420 Lexington Ave, New York, with a BBB-listed start date of 31 December 2022. It sells a wider menu than most competitors: compounded semaglutide and tirzepatide as injections, sublingual dissolvable tirzepatide tablets, microdose versions of both, plus metformin extended release, a naltrexone/bupropion/B6 combination, lipotropic MIC+B12 injections, sermorelin and NAD+.

Pricing follows the commitment ladder now common in this market. Compounded semaglutide is $99/mo on a 12-month plan billed as $1,188 prepaid, $109/mo on six months, $119/mo on three months, and $129/mo month to month. The sublingual tirzepatide page shows a similar ladder with tiers running from around $139/mo down to $69/mo depending on term and dose. The month-to-month rate of $129 is the honest comparison figure — the $99 requires handing over $1,188 at once.

On customer sentiment, bmiMD does reasonably well: 4.4 on Trustpilot across 867 verified reviews, and a claimed member base above 80,000. It also engages with BBB complaints rather than ignoring them, with 38 complaints over three years and 36 closed in the last twelve months, and visible company responses on the file. That puts it well ahead of the several providers we have reviewed this month that answer nothing.

The problems are specific and worth knowing before you pay. bmiMD is not BBB accredited. Complainants describe a $50 consultation fee they say was not disclosed at signup, prices dropping sharply after they had purchased at a higher rate, charges taken after cancellation, prepaid orders only partly fulfilled, and — most seriously for an injectable — temperature-sensitive medication shipped in a bubble-wrap envelope and arriving four days later without ever being kept on ice.

Medications Offered & Pricing

Prices reflect what bmiMD's own pages displayed on 6 August 2026. Two warnings. First, the $99 rate is a prepaid twelve-month commitment of $1,188 — compare competitors against the $129 month-to-month figure instead. Second, and specific to this provider: multiple BBB complainants report a $50 consultation fee they say was not disclosed at signup, and one describes buying sermorelin at $474 then finding the same product listed at $267. Prices here appear to move with promotions, so screenshot what you are quoted and check your first statement line by line.

Brand-Name or Compounded?

The GLP-1 products here are compounded, not brand-name. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, efficacy or manufacturing quality. There is no Ozempic, Wegovy, Mounjaro or Zepbound option.

The sublingual tirzepatide tablet warrants specific scepticism. Tirzepatide is a large peptide, and there is no FDA-approved oral form of it at all — unlike semaglutide, which has an approved oral product only because it uses a specific absorption enhancer under strict dosing conditions. A compounded sublingual tirzepatide tablet has no published clinical evidence establishing that it delivers meaningful systemic drug exposure. If you choose it to avoid needles, understand you may be paying for a dose that does not reliably reach you.

The microdose protocols are also worth understanding. Microdosing GLP-1s is not an evidence-based regimen with established outcomes; it is a lower-cost, lower-dose approach some providers offer. It may reduce side effects, and it may also reduce effect. Do not assume a microdose plan will produce the weight loss reported in trials of full therapeutic doses.

Several other items — lipotropic MIC+B12 injections, sermorelin and NAD+ — are compounded products marketed for fat metabolism, recovery and energy. The clinical evidence for those outcomes is limited, and none should be understood as a treatment for a diagnosed condition.

The Consultation Process

Eligibility

• •Eligibility is assessed by a licensed clinician from your online intake. No specific BMI threshold is published on the pages we could access.
• •State availability is not clearly published. bmiMD's pricing has been reported to differ in California and North Carolina, which suggests state-specific arrangements — confirm both availability and your price before paying.
• •GLP-1 medicines are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and must not be used in pregnancy or while trying to conceive.
• •Clinician judgement is required for anyone with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease including gastroparesis, or diabetic retinopathy.
• •Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and reflux — usually worst after a dose increase. Less common but serious risks include pancreatitis, gallbladder disease and dehydration-related kidney injury.
• •Bupropion lowers the seizure threshold and is contraindicated in people with a seizure or eating disorder history; naltrexone must not be taken by anyone using opioids. Metformin requires renal function awareness and can cause significant gastrointestinal upset.
• •Critically: if a temperature-sensitive medication arrives warm or with melted or absent cold packs, do not use it. Contact the provider and a clinician. Degraded peptide medication may be less effective and its safety cannot be assumed.

Provider Involvement, Labs & Pharmacy

Shipping & Support Services

This is bmiMD's weakest area on the public record and the reason we mark it down hardest. Compounded GLP-1s are temperature-sensitive biologics that require cold-chain handling. A BBB complainant describes medication 'shipped in bubble wrap envelope...4 days WITHOUT BEING KEPT ON ICE.' Others report medication sent despite a cancelled subscription, and prepaid multi-month orders arriving incomplete. Inspect every delivery immediately, photograph anything that arrives warm or without intact cold packs, and do not inject it.

• •Wide treatment menu — injectable and sublingual GLP-1s, microdose options, metformin, naltrexone/bupropion, sermorelin, NAD+
• •Same-day telehealth consultations advertised
• •4.4 on Trustpilot across 867 verified reviews
• •Claimed member base above 80,000
• •Responds to BBB complaints — 36 of 38 closed in the last twelve months
• •Operating since December 2022
• •Multiple plan terms from month-to-month to prepaid annual
• •Microdose protocols available for people wanting a lower-dose approach

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who bmiMD May Be Best For

• •Price-driven buyers who will take the month-to-month plan and verify every charge
• •People wanting a non-GLP-1 option such as metformin or naltrexone/bupropion alongside GLP-1 access
• •Patients interested in a microdose approach who understand the outcome data does not exist
• •Anyone who wants a wide menu from one provider and is prepared to police the billing themselves

Limitations

• •The cold-chain complaint is the one we would not look past. Compounded semaglutide and tirzepatide are peptide medicines that require refrigeration; a report of medication spending four days in a bubble-wrap envelope with no ice describes a product whose potency and safety can no longer be assumed. One complaint is not proof of a systemic problem, and bmiMD does respond to complaints — but for a weekly injectable this is the failure mode with actual clinical consequences, and it is worth knowing before you order.
• •Undisclosed fees are the second theme, and they undercut the whole pricing proposition. A $50 consultation fee that customers say did not appear before purchase turns a $129 month into a $179 one. Combined with reports of unauthorised charges and prices that fall after you have bought, the effect is that bmiMD's advertised number is less reliable than most. Get an itemised total in writing.
• •The prepaid annual plan concentrates the risk. $1,188 up front to a provider whose complaint file includes partly fulfilled prepaid orders and refunds confirmed but not paid is a poor combination. If you want to use bmiMD, the $129 month-to-month rate costs 30% more and puts almost none of your money at risk.
• •The sublingual tirzepatide is the item we would avoid entirely. There is no approved oral tirzepatide anywhere, no absorption-enhancer technology behind a compounded sublingual tablet, and no published exposure data. It is the cheapest-looking line on the menu and probably the least likely to work.
• •To be fair: bmiMD's Trustpilot standing is genuinely good, it has been trading since 2022, it answers its complaints, and it issues at least partial refunds when pressed. The picture is a competent operation with sloppy commercial controls, not a company set up to keep your money — which is a real distinction from some others in this market.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

bmiMD is one of the broader menus in this market and one of the cheaper ones. Compounded semaglutide at $129/mo month-to-month is competitive, the ladder down to $99/mo rewards commitment, and the range — injectable and sublingual GLP-1s, microdose protocols, metformin, naltrexone/bupropion, sermorelin, NAD+ — means a clinician here has real alternatives if a GLP-1 is not right for you. With 4.4 on Trustpilot across 867 reviews and a track record back to December 2022, most customers evidently get what they paid for.

The commercial controls are the problem. A $50 consultation fee that customers say appeared only after purchase, reports of unauthorised charges running into the hundreds, prices that drop below what you just paid, prepaid orders arriving incomplete, and shipments continuing after cancellation add up to a company whose advertised price you cannot fully trust. It does answer complaints and does issue partial refunds, which is more than several competitors manage — but you should not have to escalate to the BBB to get billed correctly.

The cold-chain report is the part with clinical rather than financial consequences. Refrigerated medication arriving after four days in a bubble-wrap envelope without ice is not a customer service issue; it is a product you should not inject. Inspect every delivery.

We rate bmiMD 3.0 out of 5 — a downgrade from our earlier assessment of this provider, which was written in March 2026 before the current pricing and complaint record. If the breadth of the menu is what draws you, use the $129 month-to-month plan rather than prepaying $1,188, get every fee itemised in writing first, skip the sublingual tirzepatide, and check each delivery. If you just want compounded semaglutide cheaply, CallonDoc at $89/mo has an A+ BBB rating and no prepayment requirement.

This review is informational only and is not medical advice. Compounded GLP-1s are not FDA-approved and have not been evaluated for safety, efficacy or quality. Speak to a licensed clinician about whether treatment is appropriate for you before starting, changing or stopping any medication.